IQVIA Laboratories

What if clinical success is determined long before a candidate enters the clinic? Hear Roche and IQVIA Laboratories discuss how human-relevant biology, translational science and clinic-informed discovery can help prioritize candidates, reduce risk and strengthen the path from discovery to patient impact. November 19 | Register now: https://hubs.ly/Q04BrWq00

When your discovery decisions are guided by clinical endpoints from day one, every experiment works harder for you. By grounding your work in human-relevant biology, translational science and clinic-informed discovery, you can prioritize candidates with clearer evidence, cut avoidable risk and shorten the path from idea to patient impact. Join Roche and IQVIA Laboratories on November 19 to see practical ways you can make your pipeline more predictable, more efficient and more clinically meaningful. Register now: https://hubs.ly/Q04BrWNX0

Imagine your next breakthrough starting with a patient’s story, not a Petri dish. When you bring human-relevant biology, translational science and clinic-informed discovery into the same conversation, you don’t just move a candidate forward, you give it a fighting chance to matter in real lives. Join Roche and IQVIA Laboratories on November 19 to explore how you can prioritize the right candidates, reduce painful late-stage failures and feel confident that your early decisions truly serve future patients. Register now: https://hubs.ly/Q04BrWNX0

Some of the most expensive mistakes in drug development aren't made in the clinic. They're made much earlier during discovery. Hear experts from Roche and IQVIA Laboratories discuss how human-centric approaches can help strengthen candidate selection and reduce downstream risk. Register now: https://hubs.ly/Q04BrWNX0

Many clinical setbacks can be traced back to decisions made during discovery. Join experts from Roche and IQVIA Laboratories to explore how human-relevant biology, translational science and clinic-informed discovery can help teams prioritize stronger candidates, identify risk before trials begin, and improve confidence in discovery decisions. Join the conversation so you can apply the same rigor, borrow what works and give your decision-making the authority it deserves. Register now: https://hubs.ly/Q04BrXnd0

From neurodegenerative disease and blood-brain barrier research to migraine, epilepsy and innovative disease models, our scientists are looking forward to sharing their latest research at Neuroscience 2026. Join IQVIA Laboratories in Washington, D.C., November 14-18, for eight poster presentations exploring services supporting drug discovery and development. Swipe through to meet our presenters, explore their research and find out when and where to connect with them. We look forward to seeing you at SfN 2026! Book a meeting with our team: https://hubs.ly/Q04xb0mZ0